Postoperative Immunosuppression Following Breast-Conserving Surgery vs. Mastectomy: The Role of Surgical Injuries and Intraoperative Sympathetic Activation

Postoperative Immunosuppression Following Breast-Conserving Surgery vs. Mastectomy

Authors

  • Hamid Raza Department of General Surgery, Pir Abdul Qadir Shah Jeelani Institute of Medical Sciences Gambat, Khairpur, Pakistan
  • Ayesha Inam Department of General Surgery, Med-clinic Middle East, United Arab Emirates
  • Nadir Farid Department of General Surgery, Pakistan Kidney and Liver Transplant, Lahore, Pakistan
  • . Sarang Department of General Surgery, Suleman Roshan Medical College, Tando Adam, Pakistan
  • Muhammad Azhar Qureshi Department of General Surgery, Rawal Institute of Health Sciences, Islamabad, Pakistan
  • Nawal Yousaf Department of Biochemistry, Combined Military Hospital Institute of Medical Sciences, Multan, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i09.2179

Keywords:

Breast Cancer, Surgical Tissue, Breast-Conserving Surgery, Mastectomy

Abstract

Breast cancer is the second most prevalent cancer among all types of cancers. Objectives: To evaluate the role of surgical tissue injury and intraoperative sympathetic activation in postoperative immunosuppression after breast-conservative surgery and mastectomy. Methods: This prospective/observational study investigated 36 breast cancer patients in the Department of Surgery Pir Abdul Qadir Shah Jeelani Institute of Medical Sciences, Gambat from June 2022 to May 2023. Patients who were on schedule to undergo either mastectomy or breast-conserving surgery enrolled. Patients were categorized into two groups; Group I (breast-conserving surgery group n=18) and Group II (mastectomy group n=18). The intraoperative sympathetic activation, plasma Damage-associated molecular patterns, and postoperative immune function were compared in both groups. Descriptive statistics were done using SPSS version 28.0.   Results: The overall mean age and body mass index of Group I and Group II were 62.8 ± 8.9 vs. 60.6 ± 10.6 years and 26.9 ± 3.8 vs. 25.8 ± 3.7 kg/m2, respectively. The overall duration of surgery (minutes) was 56 ± 18 and 85 ± 22, respectively. The prominent indication for surgery in Group I and Group II was Invasive carcinoma 17 (94.4%) and 11 (61.1%), respectively. The concentration of plasma alarmins and IL-6 was significantly higher in patients who underwent mastectomy as compared to breast-conserving surgery. Conclusions: It was concluded that differences in Damage-associated molecular patterns release and intraoperative sympathetic activation between mastectomy and breast-conserving surgery may influence, and potentially contribute to, postoperative immune homeostasis to improve survival seen after breast-conserving surgery.

References

Jacobs LM, Helder LS, Albers KI, Kranendonk J, Keijzer C, Joosten LA et al. The Role of Surgical Tissue Injury and Intraoperative Sympathetic Activation in Postoperative Immunosuppression After Breast-Conserving Surgery Versus Mastectomy: A Prospective Observational Study. Breast Cancer Research. 2024 Mar; 26(1): 42. doi: 10.1186/s13058-024-01801-0. DOI: https://doi.org/10.1186/s13058-024-01801-0

Al-Hilli Z and Wilkerson A. Breast surgery: Management of Postoperative Complications Following Operations for Breast Cancer. Surgical Clinics. 2021 Oct; 101(5): 845-63. doi: 10.1016/j.suc.2021.06.014. DOI: https://doi.org/10.1016/j.suc.2021.06.014

Christiansen P, Carstensen SL, Ejlertsen B, Kroman N, Offersen B, Bodilsen A et al. Breast-Conserving Surgery Versus Mastectomy: Overall and Relative Survival—A Population Based Study by the Danish Breast Cancer Cooperative Group (DBCG). Acta Oncologica. 2018 Jan; 57(1): 19-25. doi: 10.1080/0284186X.2017.1403042. DOI: https://doi.org/10.1080/0284186X.2017.1403042

Gentilini OD, Cardoso MJ, Poortmans P. Less is More. Breast Conservation Might Be Even Better Than Mastectomy in Early Breast Cancer Patients. The Breast. 2017 Oct; 35: 32-3. doi: 10.1016/j.breast.2017.06.004. DOI: https://doi.org/10.1016/j.breast.2017.06.004

Chen QX, Wang XX, Lin PY, Zhang J, Li JJ, Song CG et al. The Different Outcomes Between Breast-Conserving Surgery and Mastectomy in Triple-Negative Breast Cancer: A Population-Based Study from the SEER 18 Database. Oncotarget. 2017 Jan; 8(3): 4773. doi: 10.18632/oncotarget.13976. DOI: https://doi.org/10.18632/oncotarget.13976

Rizvi FH, Khan MK, Almas T, Ullah M, Shafi A, Murad MF et al. Early Postoperative Outcomes of Breast Cancer Surgery in a Developing Country. Cureus. 2020 Aug; 12(8). doi: 10.7759/cureus.9941. DOI: https://doi.org/10.7759/cureus.9941

Gunnarsdottir FB, Bendahl PO, Johansson A, Benfeitas R, Rydén L, Bergenfelz C et al. Serum Immuno-Oncology Markers Carry Independent Prognostic Information in Patients With Newly Diagnosed Metastatic Breast Cancer, from a Prospective Observational Study. Breast Cancer Research. 2023 Mar; 25(1): 29. doi: 10.1186/s13058-023-01631-6. DOI: https://doi.org/10.1186/s13058-023-01631-6

de Boniface J, Szulkin R, Johansson AL. Major Surgical Postoperative Complications and Survival in Breast Cancer: Swedish Population-Based Register Study in 57 152 women. British Journal of Surgery. 2022 Oct; 109(10): 977-83. doi: 10.1093/bjs/znac275. DOI: https://doi.org/10.1093/bjs/znac275

Tulotta C, Lefley DV, Moore CK, Amariutei AE, Spicer-Hadlington AR, Quayle LA et al. IL-1B Drives Opposing Responses in Primary Tumours and Bone Metastases; Harnessing Combination Therapies to Improve Outcome in Breast Cancer. Nature Portfolio Journal on Breast Cancer. 2021 Jul; 7(1): 95. doi: 10.1038/s41523-021-00305-w. DOI: https://doi.org/10.1038/s41523-021-00305-w

Selaković V, Ranisavljević M, Radovanović Z, Vicko F, Lukić D, Đurić M. Early Postoperative Complications and Local Relapses After Nipple Sparing Mastectomy and Immediate Breast Reconstruction Using Silicone Implants. Archive of Oncology. 2019 Feb; 25(1): 9-12. doi: 10.2298/AOO180701008S. DOI: https://doi.org/10.2298/AOO180701008S

Saad HA, Baz A, Riad M, Eraky ME, El-Taher A, Farid MI et al. Tumor Microenvironment and Immune System Preservation in Early-Stage Breast Cancer: Routes for Early Recurrence After Mastectomy and Treatment for Lobular and Ductal Forms of Disease. BioMed Central Immunology. 2024 Jan; 25(1): 9. doi: 10.1186/s12865-023-00591-y. DOI: https://doi.org/10.1186/s12865-023-00591-y

Lagendijk M, Van Maaren MC, Saadatmand S, Strobbe LJ, Poortmans PM, Koppert LB et al. Breast-conserving Therapy and Mastectomy Revisited: Breast Cancer‐Specific Survival and the Influence of Prognostic Factors in 129,692 Patients. International Journal of Cancer. 2018 Jan; 142(1): 165-75. doi: 10.1002/ijc.31034. DOI: https://doi.org/10.1002/ijc.31034

Ten Wolde B, Kuiper M, de Wilt JH, Strobbe LJ. Postoperative Complications After Breast Cancer Surgery Are Not Related to Age. Annals of Surgical Oncology. 2017 Jul; 24: 1861-7. doi: 10.1245/s10434-016-5726-x. DOI: https://doi.org/10.1245/s10434-016-5726-x

de Boniface J, Szulkin R, Johansson AL. Medical and Surgical Postoperative Complications After Breast Conservation Versus Mastectomy in Older Women with Breast Cancer: Swedish Population-Based Register Study of 34 139 Women. British Journal of Surgery. 2023 Mar; 110(3): 344-52. doi: 10.1093/bjs/znac411. DOI: https://doi.org/10.1093/bjs/znac411

Savioli F, Edwards J, McMillan D, Stallard S, Doughty J, Romics L. The Effect of Postoperative Complications on Survival and Recurrence After Surgery for Breast Cancer: A Systematic Review and Meta-Analysis. Critical Reviews in Oncology/Hematology. 2020 Nov; 155: 103075. doi: 10.1016/j.critrevonc.2020.103075. DOI: https://doi.org/10.1016/j.critrevonc.2020.103075

Yang X, Lin Q, Wang Q. The Impact of Breast‐Conserving Surgery and Modified Radical Mastectomy on Postoperative Wound Complications in Patients with Early Breast Cancer. International Wound Journal. 2024 Feb; 21(2): e14685. doi; 10.1111/iwj.14685. DOI: https://doi.org/10.1111/iwj.14685

Hazeldine J, Naumann DN, Toman E, Davies D, Bishop JR, Su Z et al. Prehospital Immune Responses and Development of Multiple Organ Dysfunction Syndrome Following Traumatic Injury: A Prospective Cohort Study. PLoS Medicine. 2017 Jul; 14(7): e1002338. doi: 10.1371/journal.pmed.1002338. DOI: https://doi.org/10.1371/journal.pmed.1002338

Van Boekel RL, Warlé MC, Nielen RG, Vissers KC, van der Sande R, Bronkhorst EM et al. Relationship Between Postoperative Pain and Overall 30-Day Complications in a Broad Surgical Population: An Observational Study. Annals of Surgery. 2019 May 1;269(5):856-65. doi: 10.1097/SLA.0000000000002583. DOI: https://doi.org/10.1097/SLA.0000000000002583

Odat RM, Haddadin S, Al Zoubi B, Abohalawa M, Ibrahim I, Leeper A. 99P Postoperative Adjuvant Radiotherapy in Primary Malignant Angiosarcoma of the Breast Patients Following Mastectomy or Breast-Conserving Surgery: A Retrospective Study. Journal of the European Society for Medical Oncology Open. 2024 Mar; 9. DOI: https://doi.org/10.1016/j.esmoop.2024.102488

Fancellu A, Houssami N, Sanna V, Porcu A, Ninniri C, Marinovich ML. Outcomes After Breast-Conserving Surgery or Mastectomy in Patients with Triple-Negative Breast Cancer: Meta-Analysis. British Journal of Surgery. 2021 Jul; 108(7): 760-8. doi: 10.1093/bjs/znab145. DOI: https://doi.org/10.1093/bjs/znab145

Downloads

Published

2024-09-30
CITATION
DOI: 10.54393/pjhs.v5i09.2179
Published: 2024-09-30

How to Cite

Raza, H., Inam, A., Farid, N., Sarang, ., Qureshi, M. A., & Yousaf, N. (2024). Postoperative Immunosuppression Following Breast-Conserving Surgery vs. Mastectomy: The Role of Surgical Injuries and Intraoperative Sympathetic Activation: Postoperative Immunosuppression Following Breast-Conserving Surgery vs. Mastectomy. Pakistan Journal of Health Sciences, 5(09), 150–154. https://doi.org/10.54393/pjhs.v5i09.2179

Issue

Section

Original Article

Plaudit